首页 | 本学科首页   官方微博 | 高级检索  
     

重组CD13单链抗体和蝎毒素多肽AGAP融合蛋白真核表达及对NB4 细胞的靶向杀伤作用
引用本文:倪吴花,骆超,俞康,吴建波.重组CD13单链抗体和蝎毒素多肽AGAP融合蛋白真核表达及对NB4 细胞的靶向杀伤作用[J].金属学报,2008,13(11):1231-1236.
作者姓名:倪吴花  骆超  俞康  吴建波
作者单位:1.温州医学院附属第一医院医学科学研究所,;2.血液科,;3.温州医学院, 温州 325000, 浙江
基金项目:浙江省自然科学基金资助项目(Y206383)
摘    要:目的: 本研究应用基因工程技术方法, 构建含重组编码CD13单链抗体和蝎毒素镇痛抗肿瘤缬精甘肽(analgesic antitumoral peptide, AGAP) 融合蛋白基因的表达载体, 并研究CD13-AGAP 融合蛋白对CD13 阳性白血病细胞NB4 影响。方法: 克隆东亚钳蝎活性肽AGAP 的基因, 插入真核表达载体pSecTag2 /CD13 /RFP, 得到pSecTag2 /CD13 /AGAP重组真核表达载体。酶切及测序鉴定后, 脂质体介导重组质粒转染293T 细胞, 通过RT-PCR 和免疫印迹方法检测融合基因和蛋白的表达。纯化融合蛋白, 作用NB4 细胞, CCK8 检测细胞活性, 流式细胞仪检测细胞周期。结果: 酶切及测序结果证实pSecTag2 /CD13 /AGAP 重组真核表达载体构建成功, 转染293T 细胞后, RT-PCR 和免疫印迹方法结果证实重组质粒得到有效表达, 并纯化真核表达融合蛋白CD13-AGAP 对血液肿瘤CD13阳性白血病细胞NB4 有一定的生长抑制作用, 并且使细胞周期G1 期阻滞, S 期减少。结论: 成功构建了融合蛋白真核表达载体pSecTag2 /CD13 /AGAP, 并在293T 细胞中成功表达, 进一步证实融合蛋白对CD13阳性白血病细胞NB4 有杀伤作用。

关 键 词:东亚钳蝎  蝎毒活性肽  抗肿瘤缬精甘肽  CD13单链抗体  融合蛋白  
收稿时间:2008-07-21
修稿时间:2008-10-21

Establishment of fusion protein eukaryotic expression vector of singlechain antibody fragments reacting with human CD13 and scorpion toxin polypeptide AGAP and the target lethal effect to NB4 cells
NI Wu-hua,LUO Chao,YU Kang,WU Jian-bo.Establishment of fusion protein eukaryotic expression vector of singlechain antibody fragments reacting with human CD13 and scorpion toxin polypeptide AGAP and the target lethal effect to NB4 cells[J].Acta Metallurgica Sinica,2008,13(11):1231-1236.
Authors:NI Wu-hua  LUO Chao  YU Kang  WU Jian-bo
Affiliation:1.Institute of Medical Sciences, First Affiliated Hospital of Wenzhou Medical College,;2.Department of Hematology,;3.Wenzhou Medical College, Wenzhou 325000, Zhejiang, China
Abstract:AIM: To establish the eukaryotic expression vector of single-chain antibody fragments reacting with human CD13 and scorpion toxin polypeptide analgesic antitumoral peptide (AGAP) and the target lethal effect to NB4 cells by genetic engineering method. METHODS: Buthus martensii Karsch active peptide AGAP gene was inserted eukaryotic expression vector pSecTag2 /CD13 /RFP, and the recombinate eukaryotic expression vector pSecTag2 /CD13 /AGAP was obtained. After double enzyme digestion and DNA sequencing identification, the vector was transfected into 293T cell line, the AGAP recombinant gene and protein expression were detected by RT-PCR and western blot methods. The recombinant protein was purified by ProBond(tm) Nickel-Chelating Resin kit and used to treat NB4 cells. NB4 cell cytoactive was measured by CCK-8 and the cell cycle was analyzed by FCM. RESULTS: The eukaryotic expression vector pSecTag2/ CD13 /AGAP was successfully established by double enzyme digestion and DNA sequencing identification. AGAP gene and protein expression were detected by RT-PCR and Western Blot after the vectors were transfected into 293T cells. After treatment with the purified recombinant protein CD13-AGAP, NB4 cells viability were decreased and CD13-AGAP recombinant protein arrested NB4 cell cycle in G1 phase and decreased in S phase. CONCLUSION: The recombinant plasmid pSecTag2 /CD13 /AGAP was successfully established and expressed in 293T cells, the recombinant protein CD13- AGAP had lethal effect to NB4 cells.
Keywords:Buthus martensii Karsch  scorpion venom active peptides  analgesic antitumoral peptide  CD13 single chain fragments  fusion protein  
点击此处可从《金属学报》浏览原始摘要信息
点击此处可从《金属学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号